CGS-authored
The man who led the Prop. 71 campaign receives three of the four nominations to be chairman of the state's new research institute.
December 14, 2004
Bob Klein, a Palo Alto real estate developer who has no scientific background but who ran the multimillion-dollar Proposition 71 campaign, appeared Monday to have a near-lock on the powerful job of running the state's $3-billion stem cell institute.
With Gov. Arnold Schwarzenegger, Lt. Gov. Cruz Bustamante and Controller Steve Westly each nominating Klein to head the voter-approved California Institute for Regenerative Medicine, he went from front-runner to almost certain choice when the board of directors meets for the first time Friday.
A fourth and final nomination is expected. Treasurer Phil Angelides, who must also name a candidate for chairperson, is expected to announce his choice today, a day after the deadline written into the legislation. Angelides was a key early supporter of the ballot measure.
Whoever is chosen will immediately take on one of the highest-profile positions in the controversial field of embryonic stem cell research. A 27-member board of directors _ with...
December 14, 2004
Bob Klein, a Palo Alto real estate developer who has no scientific background but who ran the multimillion-dollar Proposition 71 campaign, appeared Monday to have a near-lock on the powerful job of running the state's $3-billion stem cell institute.
With Gov. Arnold Schwarzenegger, Lt. Gov. Cruz Bustamante and Controller Steve Westly each nominating Klein to head the voter-approved California Institute for Regenerative Medicine, he went from front-runner to almost certain choice when the board of directors meets for the first time Friday.
A fourth and final nomination is expected. Treasurer Phil Angelides, who must also name a candidate for chairperson, is expected to announce his choice today, a day after the deadline written into the legislation. Angelides was a key early supporter of the ballot measure.
Whoever is chosen will immediately take on one of the highest-profile positions in the controversial field of embryonic stem cell research. A 27-member board of directors _ with...